Roaringkitty's Hidden GemI am leaving you this chart and hope you understand this is where Roaringkitty will be buying his next big move it all makes sense just look into the facts i wish you all the best and I was the first to call it...
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−25.27 USD
−666.70 M USD
219.64 M USD
16.02 M
About 23andMe Holding Co.
Sector
Industry
CEO
Anne E. Wojcicki
Website
Headquarters
Sunnyvale
Founded
2006
FIGI
BBG00XV5CYH5
23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and Research Services, and Therapeutics segments. The Consumer and Research Services segment consists of Personal Genome Service, Telehealth Business, and Research Services. The Therapeutics segment focuses on the genetic insights of genetic and phenotypic information. The company was founded by Anne E. Wojcickiin 2006 and is headquartered in Sunnyvale, CA.
KalaGhazi | 23AndMe Holdings Nov-29-22 Initiated Barenberg Buy $7
Big profits to make on this stock!
ME - Long SetupLooking for break above 2.22, Would consider stop signal of 1.97, potential first target of 2.57, 2nd potential target 3.93 based on weekly downward channel. SMDI on daily and weekly. Small insider selling in Aug, Nov and December from 3 insiders but small % and $ size.
Long term Bullish, 20 dollars, Short term BearishFirst stock analysis ever - Would love some input / criticism.
I expect ME to hit 20 some time next year, but we may see lower prices short term. I think this stock is quite undervalued even in this current overvalued market - however should the state of the current market correct properly I could
23andme long700M cash, 2.000M market cap. Transforming into DNA healthcare company. Negative Volume Index decreasing at minimums. Bargain.
Long - 23andMeGot greedy on my first theory, volume was not strong enough to break the downtrend.
Bullish bias: I don't see how 23andMe is not becoming the google of consumer genetics.
Technical analysis is based on past impulses and potential movements based on a bullish 2022 Q1-Q2 market.
Not financial advic
A Simple Analysis For A Simple SwingMy ideas are not suitable for any audience and should probably be ignored for everyones sake.
Last 2 weeks have been great! Lets go!The last 2 weeks have seen some great trends. Glad to see some movement on this important stock as we roll into earnings in Nov.
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ME is 3.17 USD — it has decreased by −1.25% in the past 24 hours. Watch 23andMe Holding Co. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange 23andMe Holding Co. stocks are traded under the ticker ME.
ME stock has fallen by −5.37% compared to the previous week, the month change is a −0.94% fall, over the last year 23andMe Holding Co. has showed a −81.47% decrease.
ME stock is 3.16% volatile and has beta coefficient of 0.95. Track 23andMe Holding Co. stock price on the chart and check out the list of the most volatile stocks — is 23andMe Holding Co. there?
Today 23andMe Holding Co. has the market capitalization of 595.31 M, it has decreased by −10.99% over the last week.
Yes, you can track 23andMe Holding Co. financials in yearly and quarterly reports right on TradingView.
23andMe Holding Co. is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
ME earnings for the last quarter are −2.32 USD per share, whereas the estimation was −3.15 USD resulting in a 26.40% surprise. The estimated earnings for the next quarter are −3.19 USD per share. See more details about 23andMe Holding Co. earnings.
23andMe Holding Co. revenue for the last quarter amounts to 44.07 M USD, despite the estimated figure of 36.41 M USD. In the next quarter, revenue is expected to reach 41.10 M USD.
ME net income for the last quarter is −59.10 M USD, while the quarter before that showed −69.40 M USD of net income which accounts for 14.84% change. Track more 23andMe Holding Co. financial stats to get the full picture.
No, ME doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 582.00 employees. See our rating of the largest employees — is 23andMe Holding Co. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 23andMe Holding Co. EBITDA is −244.93 M USD, and current EBITDA margin is −131.81%. See more stats in 23andMe Holding Co. financial statements.
Like other stocks, ME shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 23andMe Holding Co. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 23andMe Holding Co. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 23andMe Holding Co. stock shows the sell signal. See more of 23andMe Holding Co. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.